Since there is a higher level of S1P in the blood of mice and humans with SCA (36), future studies are warranted to test whether the quantity or quality of S1P receptors are diminished by SCA or other stroke risk factors, such as aging and diabetes. This evidence concerns the gene MBTPS1 and stroke disorder.